Results for tag: "Autophagy Modulator"

Autophagy modulators are a class of drugs used to treat immune disorders. They work by modulating the process of autophagy, which is the body's natural process of breaking down and recycling cellular components. Autophagy modulators can help to reduce inflammation, improve immune system function, and reduce the risk of infection. They are used to treat a variety of immune disorders, including autoimmune diseases, allergies, and chronic infections. Autophagy modulators are a relatively new class of drugs, and the market is still in its early stages. However, the potential for these drugs to treat a wide range of immune disorders has led to increased interest in the field. Companies are investing in research and development to develop new autophagy modulators and to improve existing ones. Some companies in the autophagy modulator market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more